Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Observational studies have indicated a potential association between ankylosing spondylitis and elevated cardiovascular disease (CVD) risk. However, it remains uncertain whether this association reflects a causal association. Therefore, we conducted this Mendelian randomization to investigate the causal relationship between ankylosing spondylitis and CVD.
Methods: We performed a two-sample Mendelian randomization analysis to establish a causal relationship between ankylosing spondylitis and the risk of six prevalent CVDs: hypertension, heart failure, atrial fibrillation, coronary heart disease, myocardial infarction, and peripheral artery disease. Furthermore, multivariate Mendelian randomization was employed to determine the influence of confounding factors.
Results: Genetically predicted ankylosing spondylitis increased the risk of heart failure according to the Mendelian randomization analysis (OR = 1.02; 95% CI = 1.00-1.04; = 0.030). Multivariate analysis results indicated that the causal relationship between ankylosing spondylitis and heart failure risk remained significant after adjusting for hypertension, diabetes, smoking, body mass index, and pulse wave reflection index. The associations diminished and lost significance after adjusting for pulse wave peak-to-peak time and pulse wave arterial stiffness index.
Conclusion: Genetically predicted ankylosing spondylitis increased the risk of heart failure, and the causality may partly be mediated by increased arterial stiffness.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321883 | PMC |
| http://dx.doi.org/10.3389/fcvm.2025.1415263 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Spinal fractures in patients with versus without ankylosing spinal disorders: a nationwide propensity score-matched study on survival and health-related quality of life.
J Neurosurg Spine
September 2025
1Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
Objective: The evidence on ankylosing spinal disorders (ASDs), including ankylosing spondylitis (AS) and diffuse idiopathic skeletal hyperostosis (DISH), in the context of spinal fracture stems from studies with relatively small sample sizes. There are no studies addressing the patient-reported outcome measures (PROMs) and health-related quality of life (HRQOL) outcomes associated with spinal fracture in this population. The aim of this study was to investigate differences in complications, mortality, PROMs, and HRQOL in patients with and without ASD who had been treated for spinal fracture.
View Article and Find Full Text PDFThe Risk of Rheumatic Disorders Among Patients With Rhinosinusitis: A Systematic Review and Meta-Analysis.
Int Forum Allergy Rhinol
September 2025
Division of Otolaryngology Head & Neck Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
Background: Emerging evidence suggests a possible link between rhinosinusitis and systemic rheumatic diseases; however, no meta-analysis has comprehensively examined this association to date. We aimed to investigate if patients with rhinosinusitis have a predisposition to unmasking rheumatic diseases compared to individuals without rhinosinusitis.
Methods: A comprehensive search in MEDLINE, Embase, Cochrane Library, and Web of Science was conducted until February 2025 for studies characterizing rheumatic disease incidence, prevalence, and risk in cohorts of rhinosinusitis patients.
Current Evidence on Celecoxib Safety in the Management of Chronic Musculoskeletal Conditions: An Umbrella Review.
Drugs
September 2025
Research Unit in Public Health, Epidemiology and Health Economics, University of Liege, Liege, Belgium.
Objectives: Our objective was to systematically synthesize and evaluate the existing evidence from meta-syntheses (systematic reviews and meta-analyses) reporting on the safety of celecoxib in adults with chronic musculoskeletal disorders.
Methods: We conducted a comprehensive literature search in November 2024 across MEDLINE, Cochrane Central, and Scopus databases, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines for umbrella reviews. Only systematic reviews and meta-analyses involving celecoxib safety in osteoarthritis, rheumatoid arthritis, or ankylosing spondylitis were included.
New-onset Autoimmune Diseases in Patients with Prurigo Nodularis: A Global-federated Retrospective Cohort Study.
Acta Derm Venereol
September 2025
Evidence-based Medicine Center, Chung Shan Medical University Hospital, Taichung, Taiwan; Orthopedics Department, Chi-Mei Medical Center, Tainan, Taiwan; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin,
Prurigo nodularis (PN) has been associated with autoimmune diseases, though longitudinal data are limited. This study investigates the risk of autoimmune disease development in PN patients using a global electronic health record database. This retrospective cohort study analysed data from the Global Collaborative Network within the TriNetX research network.
View Article and Find Full Text PDFGut microbiota and ankylosing spondylitis: current insights and future challenges.
Microb Cell
August 2025
Department of Biological and Morphofunctional Sciences, College of Medicine and Biological Science, Stefan cel Mare University of Suceava, 720229 Suceava, Romania.
Ankylosing spondylitis (AS) is a chronic inflammatory disease with complex pathogenesis influenced by genetic, immunological and environmental factors. Recent evidence suggests that gut microbiota significantly contributes to AS etiopathogenesis. Dysbiosis and altered immune responses in the gut potentially trigger or exacerbate the disease through intestinal barrier disruption, alteration of the IL-23/17 axis and metabolite production.
View Article and Find Full Text PDF